PEDIATRICS Vol. 57 No. 6 June 1976, pp. 948-951
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pennisi, A. J.
Right arrow Articles by Lieberman, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pennisi, A. J.
Right arrow Articles by Lieberman, E.

Cyclophosphamide in the Treatment of Idiopathic Nephrotic Syndrome

Alfred J. Pennisi M.D.1, Carl M. Grushkin M.D.1, and Ellin Lieberman M.D.1

1 Department of Pediatrics, University of Southern California School of Medicine, and the Division of Nephrology, Childrens Hospital of Los Angeles, Los Angeles

Fifty-three patients 3frac12 to 20 years of age with steroid-dependent idiopathic nephrotic syndrome (INS) were treated with cyclophosphamide and prednisone. Two dosage schedules were used: a short course (SC) at 3 to 5 mg/kg/day for six to eight weeks and a longer course (LC) at 3 to 5 mg/kg/day for eight weeks followed by 1.5 to 2.5 mg/kg for an additional four weeks. Prednisone was administered concurrently at 50 to 75 mg/sq M every other day. Twenty-nine patients were in the SC group and 24 in the LC group. The two groups did not differ significantly as to age at onset of idiopathic nephrosis nor as to the duration of the INS prior to cyclophosphamide theraphy. All patients were followed for a minimum of 42 months after cyclophosphamide therapy.

The SC was associated with a higher relapse rate during the first year than the LC (42% and 8% respectively, .01 > P < .025). At 42 months 63% of the LC group were in remission compared with 21% in the SC group.

Submitted on April 14, 1975
Accepted on July 2, 1975




This article has been cited by other articles:


Home page
 CLIN PEDIATRHome page
N. Besbas, R. Topaloglu, O. Saatci, and A. Bakkaloglu
Long-Term Follow-Up in Children with Steroid-Resistant Nephrotic Syndrome
Clinical Pediatrics, May 1, 1992; 31(5): 283 - 288.
[Abstract] [PDF]